|
Invited Speakers:
|
|
Speakers Include: Kevin Webster, Ph.D., Vice President, Oncology Research, AstraZeneca
Eric Holland, M.D., Ph.D., Director, Brain Tumor Center; Vice Chair, Translational Research, Department of Surgery, Emily Tow Jackson Chair in Oncology, Memorial Sloan Kettering Cancer Center.
Terry A. Van Dyke, Ph.D., Head, Mouse Cancer Genetics Program; Program Director, Cancer Pathways and Mechanisms, National Cancer Institute
Norman M. Greenberg, Ph.D., Vice President, Research and Development, MedImmune
David Heimbrook, Ph.D., CEO, SAIC-Frederick National Laboratory for Cancer Research
David Sidransky, MD, Chairman & Co-Founder, Champions Oncology, Inc.
Karim Dabbagh, Ph.D., Executive Director and Head, External R&D and Innovation Research Units, Pfizer Worldwide R&D
Glen N. Gaulton, Ph.D., Professor, Pathology and Laboratory Medicine; Executive Vice Dean and CSO, Perelman School of Medicine, University of Pennsylvania
Peter Pitts, President and Co-Founder, Center for Medicine in the Public Interest
Dr. Andrew L. Kung, M.D., Ph.D., Director, Pediatric Hematology, Oncology and Stem Cell Transplantation, New York-Presbyterian Morgan Stanley Children’s Hospital/Columbia University Medical Center
Jeffrey E. Green, M.D. Head, Transgenic Oncogenesis and Genomics Section, Center for Cancer Research, National Cancer Institute
Glenn Merlino, Ph.D., Chief, Molecular Genetics Section, Laboratory of Molecular Biology, Division of Basic Science, National Cancer Institute
Henry Smilowitz, Ph.D., Associate Professor, Cell Biology, University of Connecticut Health Center
Celina D’Cruz, Ph.D., Principal Scientist I, Oncology Innovative Medicines, R&D, AstraZeneca
Dylan Daniel, Ph.D., Investigator III, Oncology Pharmacology, Novartis Institutes for Biomedical Research
Neal Goodwin, Ph.D., Director, Research and Development, In Vivo Pharmacology Services, The Jackson Laboratory
Martin Carroll, M.D., Associate Professor, Division of Hematology and Oncology, University of Pennsylvania School of Medicine
Hui Gao, Ph.D., Investigator III, Novartis Institutes for Biomedical Research
Tan A. Ince, M.D., Ph.D., Director, Tumor Stem Cell Division, Interdisciplinary Stem Cell Institute and Associate Professor of Pathology, Braman Family Breast Cancer Institute, Miller School of Medicine, University of Miami
Prem K. Premsrirut, Ph.D., CEO, Mirimus, Inc.
Andrew Rhim, M.D., Instructor of Medicine, Gastroenterology/Medicine, University of Pennsylvania
Peter King, Ph.D., Senior Scientist, Molecular Imaging (Oncology), Janssen, Pharmaceutical Companies of Johnson and Johnson
Charles Glaus, Ph.D., Scientist, Research Imaging Sciences, Amgen
Werner Scheuer, Research Leader, Pharma Research and Early Development, Discovery Oncology; Roche Diagnostics GmbH
Willem Mulder, Ph.D., Associate Professor of Radiology, Director, Nanomedicine Program, Translational and Molecular Imaging Institute, Mount Sinai School of Medicine
Theresa Zhang, Ph.D., Associate Director, Merck Research Laboratories
Darrin Stuart, Senior Research Investigator II, Novartis Institutes for Biomedical Research
Erica Jackson, Ph.D., Scientist, Research Group Leader, Genentech
Chandan Kumar-Sinha, Ph.D., Research Assistant Professor, Pathology, University of Michigan
|
|